Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Die Ophthalmologie

04.03.2024 | Uveitis | Leitlinien, Stellungnahmen und Empfehlungen

Nicht-infektiöse anteriore Uveitis

S1-Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbands der Augenärzte Deutschlands (BVA). Version: 13.12.2023

verfasst von: Deutsche Ophthalmologische Gesellschaft (DOG), Berufsverband der Augenärzte Deutschlands e. V. (BVA)

Erschienen in: Die Ophthalmologie

Einloggen, um Zugang zu erhalten

Auszug

Hilfestellung bei einer sinnvollen und gezielten Diagnostik bei einer zwar relativ häufigen, aber eventuell zu schwerer Sehminderung führenden Krankheit. Assoziationen zu entzündlich-rheumatischen Erkrankungen bzw. anderen entzündlichen Systemerkrankungen sind möglich und haben einen Einfluss auf die Therapie. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Abela-Formanek C, Amon M, Schauersberger J et al (2002) Results of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in uveitic eyes with cataract: comparison to a control group. J Cataract Refract Surg 28(Ib):1141–1152PubMedCrossRef
2.
Accorinti M, Iannetti L, Liverani M et al (2010) Clinical features and prognosis of HLA B27-associated acute anterior uveitis in an Italian patient population. Ocul Immunol Inflamm 18(III):91–96PubMedCrossRef
3.
Al Obeidan SA, Osman EA, Al-Muammar AM et al (2009) Efficacy and safety of deep sclerectomy in uveitic glaucoma. Int Ophthalmol 29(II):367–372PubMedCrossRef
4.
Alio JL, Chipont E, BenEzra D et al (2002) Comparative performance of intraocular lenses in eyes with cataract and uveitis. J Cataract Refract Surg 28(Ib):2096–2108PubMedCrossRef
5.
Amara A, Salah BE, Guihot A et al (2021) Observational study of QuantiFERON® management for ocular tuberculosis diagnosis: analysis of 244 consecutive tests. Rev Med Interne 42(II):162–169PubMedCrossRef
6.
Ang M, Htoon HM, Chee SP (2009) Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology 116(III):1391–1396PubMedCrossRef
7.
Ang M, Wong W, Ngan CCL, Chee SP (2012) Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye 26(II):658–665PubMedPubMedCentralCrossRef
8.
Auer C, Mermoud A, Herbort CP (2004) Deep sclerectomy for the management of uncontrolled uveitic glaucoma: preliminary data. Klin Monatsbl Augenheilkd 221(III):339–342PubMed
9.
Baarsma GS, La Hey E, Glasius E et al (1987) The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol 104(III):211–217PubMedCrossRef
10.
Baltatzis S, Tufail F, Yu EN et al (2003) Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology 110(III):1061–1065PubMedCrossRef
11.
Behndig A, Cochener-Lamard B, Guell J et al (2015) Surgical, antiseptic, and antibiotic practice in cataract surgery: results from the European Observatory in 2013. J Cataract Refract Surg 42(IIb):2635–2643CrossRef
12.
BenEzra D, Cohen E, Chajek T et al (1988) Evaluation of conventional therapy versus cyclosporine A in Behcet’s syndrome. Transplant Proc 20(Ib):136–143PubMed
13.
Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T et al (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 14:340–343PubMedCrossRef
14.
Bodaghi B, Gendron G, Wechsler B et al (2007) Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol 91(III):335–339PubMedCrossRef
15.
Brandt J, Listing J, Haibel H et al (2005) Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis. Rheumatology 44(II):342–348PubMedCrossRef
16.
Braun J, Baraliakos X, Listing J et al (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52(III):2447–2451PubMedCrossRef
17.
Bucci Larochelle M, Smith J, Dacey MS (2016) Dexamethason intravitreal implant in the treatment of uveitic macular edema in the perioperative cataract setting: a case series. Am J Ophthalmol 166(III):149–153CrossRef
18.
Bui TT, Rosdahl JA (2022) Systemic review of MIGS and non-penetrating glaucoma procedures for uveitis glaucoma. Semin Ophthalmol 37(IV):830–838PubMedCrossRef
19.
Cagini C, Pellegrino A, Cerquaglia A et al (2020) Comparison of the effect of diclofenac 0.1 % and nepafenac 0.1 % on aqueous flare in patients undergoing cataract surgery: a prospective randomized study. Curr Eye Res 45(Ib):1089–1093PubMedCrossRef
20.
Cazana IM, Böhringer D, Reinhard T et al (2022) A comparison of long-term results after Baerveldt 250 implantation in advanced uveitic vs. other forms of glaucoma. Graefes Arch Clin Exp Ophthalmol 260(III):2991–3000PubMedPubMedCentralCrossRef
21.
Ceballos EM, Beck AD, Lynn MJ (2002) Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 11(III):189–196PubMedCrossRef
22.
Ceballos EM, Parrish RK 2nd, Schiffman JC (2002) Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 109(III):2256–2260PubMedCrossRef
23.
Chang JH, McCluskey PJ, Wakefield D (2005) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 50(III):364–388PubMedCrossRef
24.
Chow A, Burkemper B, Varma R et al (2018) Comparison of surgical outcomes of trabeculectomy, Ahmed shunt, and Baerveldt shunt in uveitic glaucoma. J Ophthalmic Inflamm Infect 8(9):III
25.
Conen D, Schwarz U (1982) Uveitis: a rational diagnostic program for practice in internal medicine. Schweiz Med Wochenschr 112(III):22–25PubMed
26.
Couret C, Servant M, Lebranchu P et al (2020) Efficacy and safety of interferon alpha 2a and pegylated interferon alpha 2a in inflammatory macular edema. Ocul Immunol Inflamm 28(III):329–336PubMedCrossRef
27.
Dada T, Dhawan M, Garg S et al (2007) Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitis cataract. J Cataract Refract Surf 33(Ib):1613–1618CrossRef
28.
Davis JC Jr, Van Der Heijde D, Braun J et al (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48(Ib):3230–3236PubMedCrossRef
29.
De Parisot A, Kodjikian L, Errera MH et al (2017) Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ELISSE). Am J Ophthalmol 178(Ib):176–185PubMedCrossRef
30.
de Vries J, Baarsma GS, Zaal MJ et al (1990) Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br J Ophthalmol 74(Ib):344–349PubMedCrossRef
31.
Deuter CME, Kötter I, Günaydin I et al (2009) Efficacy and tolerability of interferon alpha treatmentn patients with chronic cystoid macular edema due to non-infectious uveitis. Br J Ophthalmol 93(III):906–913PubMedCrossRef
32.
Donnenfeld ED, Nichamin LD, Hardten DR et al (2011) Twice-daily, preservative-free ketorolac 0.45 % for treatment of inflammation and pain after cataract surgery. Am J Ophthalmol 151(Ib):420–426.e1PubMedCrossRef
33.
Dunne JA, Travers JP (1979) Double-blind clinical trial of topical steroids in anterior uveitis. Br J Ophthalmol 63(Ib):762–767PubMedCrossRef
34.
Dunne JA, Jacobs N, Morrison A et al (1985) Efficacy in anterior uveitis of two known steroids and topical tolmetin. Br J Ophthalmol 69(Ib):120–125PubMedCrossRef
35.
Elgohary MA, McCluskey PJ, Towler HM et al (2007) Outcome of phacoemulsification in patients with uveitis. Br J Ophthalmol 91(III):916–921PubMedCrossRef
36.
El-Shabrawi Y, Hermann J (2002) Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology 109(II):2342–2346PubMedCrossRef
37.
Evans M, Sharma O, LaBree L et al (2007) Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 114(III):325–333PubMedCrossRef
38.
Falappone PC, Iannone F, Scioscia C et al (2004) The treatment of recurrent uveitis with TNF-alpha inhibitors. Reumatismo 56(II):185–189PubMed
39.
Feldtkeller E, Khan MA, van der Heijde D et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(III):61–66PubMedCrossRef
40.
Feltkamp TE, Ringrose JH (1998) Acute anterior uveitis and spondyloarthropathies. Curr Opin Rheumatol 10(III):314–318PubMedCrossRef
41.
Fernandez-Melon JS, Munoz-Fernandez S, Hidalgo V et al (2004) Uveitis as the initial clinical manifestation in patients with spondyloarthropathies. J Rheumatol 31(II):524–527PubMed
42.
Fearnley IR, Rosenthal AR (1995) Fuchs’ heterochromic iridocyclitis revisited. Acta Ophthalmol Scand 73(III):166–170PubMedCrossRef
43.
Fukami R, Ohba S, Ishida K et al (1994) Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis. Nippon Ganka Gakkai Zasshi 98(II):287–292PubMed
44.
45.
Garcia de Cortazar LC, Alvarado C (1991) Las Heras J Interstitial nephritis syndrome and uveitis. Rev chil pediatr 62(III):252–256PubMed
46.
Gaudio PA (2004) A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. Ocul Immunol Inflamm 12(III):169–192PubMedCrossRef
47.
Goulet RJ 3rd, Phan AD, Cantor LB et al (2008) Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 115(II):1141–1147PubMedCrossRef
48.
Gran JT, Ostensen M (1985) Husby G A clinical comparison between males and females with ankylosing spondylitis. J Rheumatol 12(III):126–129PubMed
49.
Guex-Crosier Y (1999) Epidemiology of uveitis. Rev Prat 49(III):1989–1994PubMed
50.
Hatemi G, Silman A, Bang D et al (2008) EULAR recommendations for the management of Behcet’s disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 67(III):1656–1662PubMedCrossRef
51.
Hedayatfar A, Hashemii H, Asgari S et al (2014) Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment of acute anterior uveitis. Cornea 33(Ib):366–372PubMedCrossRef
52.
Heiligenhaus A, Niewerth M, Ganser G et al (2007) Prevalence and complications of uveitis in juvenile idiopahic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Baillieres Clin Rheumatol 46(II):1015–1019
53.
Heinz C, Zurek-Imhoff B, Koch J et al (2011) Long-term reduction of laser flare values after trabeculectomy but not after cyclodestructive procedures in uveitis patients. Int Ophthalmol 31(III):205–210PubMedCrossRef
54.
Hirneiss C, Neubauer AS, Kampik A et al (2005) Comparison of prednisolone 1 %, rimexolone 1 % and ketorolac tromethamine 0.5 % after cataract extraction: a prospective, randomized, double-masked study. Graefes Arch Clin Exp Ophthalmol 243(Ib):768–773PubMedCrossRef
55.
Huhtinen MA, Karma A (2000) HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol 84(II):413–416PubMedPubMedCentralCrossRef
56.
Huhtinen M, Repo H, Laasila K et al (2002) Systemic inflammation and innate immune response in patients with previous anterior uveitis. Br J Ophthalmol 86(II):412–417PubMedPubMedCentralCrossRef
57.
Huppertz HI, Munchmeier D, Lieb W (1999) Ocular manifestations in children and adolescents with Lyme arthritis. Br J Ophthalmol 83(III):1149–1152PubMedPubMedCentralCrossRef
58.
Isogai E, Isogai H, Kotake S et al (1991) Detection of antibodies against Borrelia burgdorferi in patients with uveitis. Am J Ophthalmol 112(II):23–30PubMedCrossRef
59.
Jabs DA, Rosenbaum JT, Foster CS et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130(III):492–513PubMedCrossRef
60.
Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(III):509–516PubMed
61.
Jaffe GF, Foster CS, Pavesio CE et al (2019) Effect of an injectible fluocinolone acetonide insert on recurrence rates in chronic noninfectious uveitis affecting the posterior segment: twelve-month results. Ophthalmology 126(Ib):601–610PubMedCrossRef
62.
Jin Y, Lu S, Lin Y et al (2022) The efficacy and safety of TNF inhibitor (golimumab) as salvage treatment in patients with refractory noninfectious uveitis. Immunopharmacology 30(III):1363–1368
63.
Jones NP (1991) Fuchs’ Heterochromic Uveitis: a reappraisal of the clinical spectrum. Eye 5(III):649–661PubMedCrossRef
64.
65.
Kaplan-Messas A, Barkana Y, Avni I et al (2003) Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis. Ocul Immunol Inflamm 11(III):131–139PubMedCrossRef
66.
Karim R, Sykakis E, Lightman S, Fraser-Bell S (2013) Interventions for the treatment of uveitic macular edema: a systemic review and meta-analysis. Clin Ophthalmol 7(II):1109–1144PubMedPubMedCentralCrossRef
67.
Kazi H, de Groot-Mijnes JDF, Ten Dam-van Loon NH et al (2016) No value for routine serologic screening for borrelia burgdorferi in patients with uveitis in the Netherlands. Am J Ophthalmol 166(II):189–193PubMedCrossRef
68.
69.
Kiltz U, Braun J, Becker A et al (2019) Long version of the S3 guidelines for axial spondyloarthritis including bechterew’s disease and early forms, update 2019: evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations. Z Rheumatol 78(II):3–64PubMedCrossRef
70.
Kotaniemi K, Kotaniemi A (2002) Savolainen A Uveitis as a marker of active arthritis in 372 patients with juvenile idiopathic seronegative oligoarthritis or polyarthritis. Clin Exp Rheumatol 20(II):109–112PubMed
71.
Kothari S, Foster CS, Pistilli M et al (2015) The risk of intraocular pressure elevation in pediatric non-infectious uveitis. Ophthalmology 122(III):1987–2001PubMedCrossRef
72.
Kötter I, Zierhut M, Eckstein AK et al (2003) Human recombinant interferon alfa-2a for the treatment of Behcet’s disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87(II):423–431PubMedPubMedCentralCrossRef
73.
Li J, Heinz C, Zureck-Imhoff B, Heiligenhaus A (2006) Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritia. J Cataract Refract Surg 32(III):1535–1539PubMedCrossRef
74.
Liakopoulos V, Ioannidis I, Zengos N et al (2006) Tubulointerstitial nephritis and uveitis (TINU) syndrome in a 52-year-old female: a case report and review of the literature. Ren Fail 28(III):355–359PubMedCrossRef
75.
Lindsley CB, Petty RE (2000) Overview and report on international registry of sarcoid arthritis in childhood. Curr Rheumatol Rep 2(II):343–348PubMedCrossRef
76.
Ling Q, Cai Z, Zhang X, Duan X (2023) the efficacy and safety of micropulse transscleral laser treatment in glaucoma: a systemic review and meta-analysis. BMC Ophthalmol 23:263PubMedPubMedCentralCrossRef
77.
Linssen A, Dekker-Saeys AJ, Dijkstra PF et al (1986) The use of HLA-B27 as a diagnostic and prognostic aid in acute anterior uveitis (AAU) in The Netherlands. Doc Ophthalmol 64(II):217–223PubMed
78.
Linssen A, Rothova A, Valkenburg HA et al (1991) The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 32(III):2568–2578PubMed
79.
Lommatzsch C, Heinz C, Heiligenhaus A, Koch JM (2016) Canaloplasty in patients with uveitis glaucoma: a pilot study. Graefes Arch Clin Exp Ophthalmol 254(III):1325–1230PubMedCrossRef
80.
Loteprednol etabonate US Uveitis Study Group (1999) Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol etabonate US Uveitis Study Group. Am J Ophthalmol 127(Ib):537–544
81.
Mackensen F, Heinz C, Becker MD, Heiligenhaus A (2008) Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study. Retina 28(III):41–45PubMedCrossRef
82.
Mackensen F, Heinz C, Jakob E et al (2018) Randomized controlled study to evaluate the efficacy of adalimumab in patients with different forms of refractory uveitis. Ocul Immunol Inflamm 26(Ib):1015–1022PubMedCrossRef
83.
Mandeville JT, Levinson RD, Holland GN (2001) The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46(III):195–208PubMedCrossRef
84.
Markomichelakis N, Delicha E, Masselos S et al (2011) A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet’s disease: a comparative 4‑week study. Baillieres Clin Rheumatol 50(II):593–597
85.
Masuda K, Nakajima A, Urayama A et al (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet’s disease. Lancet 1(Ib):1093–1096PubMedCrossRef
86.
McCannel CA, Holland GN, Helm CJ et al (1996) Causes of uveitis in the general practice of ophthalmology. UCLA community-based uveitis study group. Am J Ophthalmol 121(III):35–46PubMedCrossRef
87.
Mercanti A, Parolini B, Bonora A et al (2001) Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand 79(III):64–68PubMedCrossRef
88.
Mehta S, Linton MM, Kempen JH (2014) Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol 158(III):676–692.e7PubMedCrossRef
89.
Monnet D, Breban M, Hudry C et al (2004) Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 111(III):802–809PubMedCrossRef
90.
Mora P, Gonzales S, Ghirardini S et al (2016) Perioperative prophylaxis to prevent recurrence following cataract surgery in uveitic patients: a two-centre, prospective, randomized trial. Acta Ophthalmol 94(Ib):e390–4PubMed
91.
Munoz-Fernandez S, Garcia-Aparicio AM, Hidalgo MV et al (2009) Methotrexate: an option for preventing the recurrence of acute anterior Uveitis. Eye 23(II):1130–1133PubMedCrossRef
92.
Najjar DM, Cohen EJ, Rapuano CJ et al (2004) EDTA chelation for calcific band keratopathy: results and long-term follow-up. Am J Ophthalmol 137(III):1056–1064PubMedCrossRef
93.
Noble J, Derzko-Dzulynsky L, Rabinovitch T et al (2007) Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. Can J Ophthalmol 42(III):89–94PubMedCrossRef
94.
Noor Sunba MS, Al-Awqati M, Sherriff SM (1988) The diagnostic significance of serological screening of patients with uveitis. Acta Ophthalmol 66(II):709–712CrossRef
95.
Nussenblatt RB, Palestine AG, Chan CC et al (1991) Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 112(Ib):138–146PubMedCrossRef
96.
Ohguro N, Yamannaka E, Otori Y et al (2006) Repeated intravitreal triamcinolone injections in Behçet disease that is resistant to conventional therapy: one year results. Am J Ophthalmol 141(II):218–220PubMedCrossRef
97.
Ossewaarde-van Norel J, Berg EM, Sijssens KM, Rothova A (2011) Subfoveal serous retinal detachment in patients with macular edema. Arch Ophthalmol 129(II):158–162PubMedCrossRef
98.
Ozdal PC, Vianna RN, Deschenes J (2006) Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye 20(III):178–183PubMedCrossRef
99.
Ozer MD, Kebapci F, Batur M et al (2019) In vivo analysis and comparison of anterior segment structures of both eyes in unilateral Fuchs uveitis syndrome. Graefes Arch Clin Exp Ophthalmol 257(II):1489–1498PubMedCrossRef
100.
Paganelli F, Cardillo JA, Melo LAS Jr et al (2004) A single intraoperative sub-tenon’s capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology 111(Ib):2102–2108PubMedCrossRef
101.
Paivonsalo-Hietanen T, Tuominen T, Vaahtoranta-Lehtonen H et al (1997) Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand 75(III):76–81PubMedCrossRef
102.
Paivonsalo-Hietanen T, Tuominen J (2000) Saari KM Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 78(III):84–88PubMedCrossRef
103.
Papadaki TG, Zacharopoulos IP, Pasquale LR et al (2007) Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol 144(III):62–69PubMedCrossRef
104.
105.
Pepple KL, Nguyen MH, Pakzad-Vaezi K et al (2019) Response of inflammatory cystoid macular edema to treatment using oral acetazolamide. Retina 39(III):948–955PubMedPubMedCentralCrossRef
106.
Plskova J, Greiner K (2007) Forrester JV Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis. Am J Ophthalmol 144(IIa):55–61PubMedCrossRef
107.
Popova LI, Plotnikova Iu A (2002) Chuprov AD Clinical picture and differential diagnosis of anterior granulomatous uveitis. Probl Tuberk 11(III):33–34
108.
Prata JA Jr, Neves RA, Minckler DS et al (1994) Trabeculectomy with mitomycin C in glaucoma associated with uveitis. Ophthalmic Surg 25(III):616–620PubMed
109.
Puska PM (2007) Tarkkanen AH Transscleral red laser cyclophotocoagulation for the treatment of therapy-resistant inflammatory glaucoma. Eur J Ophthalmol 17(III):550–556PubMedCrossRef
110.
Quereshi A, Jones NP, Au L (2019) Urgent management of secondary glaucomy in uveitis using xen-45 gel stent. J Glaucoma 28(III):1061CrossRef
111.
Rademacher J, Müllner H, Diekhoff T et al (2023) Keep an eye on the back: spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol 75(II):210–219PubMedCrossRef
112.
Ragam AP, Kolomeyer AM, Nayak NV, Chu DS (2015) The use of Ozurdex (dexamethason intravitreal implant) during anterior segment surgery in patients with chronic recurrent uveitis. J Ocul Pharmacol Ther 31(III):344–349PubMedCrossRef
113.
Ramanan AV, Dick AD, Jones AP et al (2017) Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med 376(Ib):1637–1646PubMedCrossRef
114.
Ramdas WD, Pals J, Rothova A, Wolfs RCW (2019) Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature. Graefes Arch Clin Exp Ophthalmol 257(II):143–151PubMedCrossRef
115.
Redeker I, Siegmund B, Ghoreschi K et al (2020) The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study. Ther Adv Musculoskelet Dis 12(II):1759720X20972610PubMedPubMedCentral
116.
Reeves SW, Sloan FA, Lee PP et al (2006) Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. Ophthalmology 113(III):307.e301
117.
Roesel M, Heinz C, Heimes B et al (2008) Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis—a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 246(Ib):1609–1615PubMedCrossRef
118.
Roesel M, Gutfleisch M, Heinz C et al (2009) Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study. Ophthalmic Res 42(III):81–86PubMedCrossRef
119.
Roesel M, Heinz C, Koch JM, Heiligenhaus A (2010) Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol 248(Ib):715–720PubMedCrossRef
120.
Rudwaleit M, Rodevand E, Holck P et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 68(Ib):696–701PubMedCrossRef
121.
Rudwaleit M, Haibel H, Baraliakos X et al (2009) The early disease stage in axial spondyloarthritis—results from the German spondyloarthritis inception cohort (GESPIC). Arthritis Rheum 60(II):717–727PubMedCrossRef
122.
123.
Samson CM, Waheed N, Baltatzis S et al (2001) Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 108(III):1134–1139PubMedCrossRef
124.
Sato T, Minakucchi S, Mochizuki M et al (2014) Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis. Clin Ophthalmol 8(III):187–190PubMedPubMedCentralCrossRef
125.
Siepmann K, Huber M, Stubiger N et al (2006) Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol 244(III):788–794PubMedCrossRef
126.
Sinha S, Ganjei AY, McWatters Z et al (2020) Ahmed versus Baerveldt glaucoma drainage device in uveitis glaucoma: a retrospective comparative study. J Glaucoma 29(III):750–755PubMedCrossRef
127.
128.
Smith JR, Coster DJ (1998) Diagnosing the systemic associations of anterior uveitis. Aust N Z J Ophthalmol 26(III):319–326PubMedCrossRef
129.
Souissi K, El Afrit MA, Trojet S et al (2006) Deep sclerectomy for the management of uveitic glaucoma. J Fr Ophtalmol 29(II):265–268PubMedCrossRef
130.
Souza C, Tran DH, Loman J et al (2007) Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol 144(II):893–900PubMedCrossRef
131.
Starr M, Donnenfeld E, Newton M et al (1996) Excimer laser phototherapeutic keratectomy. Cornea 15(III):557–565PubMed
132.
Stavrou P, Linton S, Young DW et al (1997) Clinical diagnosis of ocular sarcoidosis. Eye 11(II):365–370PubMedCrossRef
133.
Stewart OG, Morrell AJ (2003) Management of band keratopathy with excimer phototherapeutic keratectomy: visual, refractive, and symptomatic outcome. Eye 17(III):233–237PubMedCrossRef
134.
Stiefel HC, Kopplin LJ, Albini T et al (2021) Treatment of refractory cystoid macular edema with pegylated interferon alpha 2a: a retrospective chart review. Ocul Immunol Inflamm 29(III):566–571PubMedCrossRef
135.
Strehl C, Bijlsma JW, De Wit M et al (2016) Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forcee. Ann Rheum Dis 75(Ib):952–957PubMedCrossRef
136.
Tan AN, Cornelissen MF, Webers CAB et al (2018) Outcomes of severe uveitis glaucoma treated with Baerveldt implant: can blindness be prevented? Acta Ophthalmol 96(III):24–30PubMedCrossRef
137.
Teoh SC, Hogan AC, Dick AD et al (2008) Mycophenolate Mofetil for the treatment of Uveitis. Am J Ophthalmol 146(II):752–760PubMedCrossRef
138.
139.
Tran VT, Auer C, Guex-Crosier Y et al (1994) Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol 18(III):293–298PubMedCrossRef
140.
Tunaci A, Berkmen YM (1995) Gokmen E Thoracic involvement in Behcet’s disease: pathologic, clinical, and imaging features. AJR Am J Roentgenol 164(III):51–56PubMedCrossRef
141.
Uludag G, Karaca I, Akhavanrezayat A et al (2022) Efficacy and safety of tocilizumab in the management of noninfectious uveitis failed with conventional immunomodulatory and anti-TNFalpha therapy. Ocul Immunol Inflamm 21(III):1–7CrossRef
142.
Van Bentum RE, Heslinga SC, Nurmohamed MT et al (2019) Reduced occurrence rate of acute anterior uveitis in ankylosing spondylitis treated with golimumab—the GO-EASY study. J Rheumatol 46(Ib):153–159PubMedCrossRef
143.
Van der Horst-Bruinsma I, van Bentum R, Verbraak FD et al (2020) The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C‑VIEW. RMD Open 6(Ib):e1161–1PubMedPubMedCentralCrossRef
144.
Vegas-Revenga N, Calvo-Rio V, Mesquida M et al (2019) Anti-IL6-receptor tocilizum ab in refractory and noninfectious uveitic cystoid macular edema: multicenter study of 25 patients. Am J Ophthalmol 200(III):85–94PubMedCrossRef
145.
Vinje O, Moller P, Mellbye J (1984) Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew’s syndrome) and their relatives. Clin Rheumatol 3(II):501–513PubMedCrossRef
146.
Vohra S, Eddy A, Levin AV et al (1999) Tubulointerstitial nephritis and uveitis in children and adolescents. Four new cases and a review of the literature. Pediatr Nephrol 13(III):426–432PubMedCrossRef
147.
Voykov B, Deuter C, Zierhut M et al (2014) Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs uveitis syndrome? Graefes Arch Clin Exp Ophthalmol 252(III):485–489PubMedCrossRef
148.
Wakefield D (1985) Methylprednisolone pulse therapy in severe anterior uveitis. Aust N Z J Ophthalmol 13(III):411–415PubMedCrossRef
149.
Wakefield D, Montanaro A (1991) McCluskey P Acute anterior uveitis and HLA-B27. Surv Ophthalmol 36(III):223–232PubMedCrossRef
150.
Walters TR, Goldberg DF, Peace JH et al (2014) Bromfenac ophthalmic solution 0.07 % dosed once daily for cataract surgery: results of 2 randomized controlled trials. Ophthalmology 121(Ib):25–33PubMedCrossRef
151.
Wang B, Dong N, Liu J et al (2013) Efficacy and safety of intracameral triamcinolone acetonide to control postoperative inflammation after phacotrabeculectomy. J Cataract Refract Surg 39(III):1691–1697PubMedCrossRef
152.
Woreta F, Thorne JE, Jabs DA et al (2007) Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 143(III):647–655PubMedCrossRef
153.
Yalvac IS, Sungur G, Turhan E et al (2004) Trabeculectomy with mitomycin‑C in uveitic glaucoma associated with Behcet disease. J Glaucoma 13(III):450–453PubMedCrossRef
154.
Yazici H, Pazarli H, Barnes CG et al (1990) A controlled trial of azathioprine in Behcet’s syndrome. N Engl J Med 322(Ib):281–285PubMedCrossRef
155.
Zaczek A, Artzen D, Laurell CG et al (2014) Nepafenac 0.1 % plus dexamethasone 0.1 % versus dexamethasone alone: effect on macular swelling after cataract surgery. J Cataract Refract Surg 40(Ib):1498–1505PubMedCrossRef
156.
Zeboulon N, Dougados M, Gossec L (2008) Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis 67(II):955–959PubMedCrossRef
Metadaten
Titel
Nicht-infektiöse anteriore Uveitis
S1-Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbands der Augenärzte Deutschlands (BVA). Version: 13.12.2023
verfasst von
Deutsche Ophthalmologische Gesellschaft (DOG)
Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Publikationsdatum
04.03.2024
Verlag
Springer Medizin
Erschienen in
Die Ophthalmologie
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-024-02007-7

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Therapieverfahren in der Augenheilkunde CME-Artikel

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Erkrankungen der Hornhaut CME-Artikel

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise